New ETF Book by Larry Connors - Click here to read more
Shojiro Morishita, General Manager of Chem & Bio Informatics department said, "Dotmatics products allow researchers to handle disparate databases easily and have effective visualization tools for efficient decision making in drug discovery." We can expand our business for supporting drug discovery using Dotmatics technology including database system, data management, SAR and visualization. We are very excited about launching the Dotmatics' state-of-the-art solutions to researchers in the Japanese market.
About Infocom
Infocom Corporation offers a variety of IT services and solutions. The Chem & Bio Informatics Department has provided solutions for over 25 years in the drug discovery space covering Chem/Bio-informatics, Proteomics, Drug Design, ADMET and drug development. The department is serving clients in different areas of from research to pre-Clinical and Clinical.
Bill Bailey Global Account Manager at Dotmatics, said: "We are delighted to be working with Infocom and are now able to provide the Japanese marketplace with solutions that will enhance the way that data can be queried and visualised, within the framework of a flexible licensing model."
About Dotmatics
Dotmatics is a scientific software company deploying web-based knowledge solutions that dramatically improve the way scientific data is queried, browsed, managed, shared and visualised within companies. Dotmatics has significant expertise in cheminformatics techniques including chemical databases, SAR analysis, data management and data visualization.
The Dotmatics suite includes:
Browser- a query and visualization tool for biological and chemical datasets.
Pinpoint(1)- an Oracle cartridge allowing rapid indexing and searching of chemical databases.
Gateway- a centralised depot for sharing information with colleagues and external collaborators.
Nucleus- a web-based tool for importing, mapping and storing data from existing sources.
Register- a web-based tool for single and batch compound registration.
Vortex- an advanced visualization and analytics tool for scientific and non-scientific data.
For further information please visit www.dotmatics.com.
(1) Pinpoint is developed in collaboration with Astex Therapeutics Ltd
SOURCE: Dotmatics Limited
Dotmatics Ltd Bill Bailey Global Account Manager +44 (0)1279 654 123 bb@dotmatics.com
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
10 Exchange Place, Suite 1800
Jersey City, NJ 07302
© Copyright 2009 The Connors Group, Inc.
